Skip to main content

Research Repository

Advanced Search

Production and Application of Multicistronic Constructs for Various Human Disease Therapies

Shaimardanova, Alisa A.; Kitaeva, Kristina V.; Abdrakhmanova, Ilmira I.; Chernov, Vladislav M.; Rutland, Catrin S.; Rizvanov, Albert A.; Chulpanova, Daria S.; Solovyeva, Valeriya V.

Production and Application of Multicistronic Constructs for Various Human Disease Therapies Thumbnail


Authors

Alisa A. Shaimardanova

Kristina V. Kitaeva

Ilmira I. Abdrakhmanova

Vladislav M. Chernov

Albert A. Rizvanov

Daria S. Chulpanova

Valeriya V. Solovyeva



Abstract

The development of multicistronic vectors has opened up new opportunities to address the fundamental issues of molecular and cellular biology related to the need for the simultaneous delivery and joint expression of several genes. To date, the examples of the successful use of multicistronic vectors have been described for the development of new methods of treatment of various human diseases, including cardiovascular, oncological, metabolic, autoimmune, and neurodegenerative disorders. The safety and effectiveness of the joint delivery of therapeutic genes in multicistronic vectors based on the internal ribosome entry site (IRES) and self-cleaving 2A peptides have been shown in both in vitro and in vivo experiments as well as in clinical trials. Co-expression of several genes in one vector has also been used to create animal models of various inherited diseases which are caused by mutations in several genes. Multicistronic vectors provide expression of all mutant genes, which allows the most complete mimicking disease pathogenesis. This review comprehensively discusses multicistronic vectors based on IRES nucleotide sequence and self-cleaving 2A peptides, including its features and possible application for the treatment and modeling of various human diseases.

Citation

Shaimardanova, A. A., Kitaeva, K. V., Abdrakhmanova, I. I., Chernov, V. M., Rutland, C. S., Rizvanov, A. A., …Solovyeva, V. V. (2019). Production and Application of Multicistronic Constructs for Various Human Disease Therapies. Pharmaceutics, 11, 580. https://doi.org/10.3390/pharmaceutics11110580

Journal Article Type Article
Acceptance Date Nov 3, 2019
Online Publication Date Nov 6, 2019
Publication Date Nov 6, 2019
Deposit Date Nov 8, 2019
Publicly Available Date Mar 29, 2024
Journal Pharmaceutics
Electronic ISSN 1999-4923
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 11
Pages 580
DOI https://doi.org/10.3390/pharmaceutics11110580
Keywords 2A peptides; IRES; Multicistronic constructs; Gene therapy; Neurodegenerative diseases; Metabolic diseases; Cancer; Autoimmune diseases; Cardiovascular diseases
Public URL https://nottingham-repository.worktribe.com/output/3083255
Publisher URL https://www.mdpi.com/1999-4923/11/11/580

Files




You might also like



Downloadable Citations